[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-06", "acceptance_datetime": "2025-11-06T21:26:55Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-25-269680", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-25-269680/files/ntla-20250930_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -100987000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -100987000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -100987000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_earnings_per_share": {"value": -0.92, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "costs_and_expenses": {"value": 125259000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "benefits_costs_expenses": {"value": 125259000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -101324000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 125259000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -111477000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_earnings_per_share": {"value": -0.92, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -101324000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 94747000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -101324000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -111477000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "other_operating_expenses": {"value": 30512000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "revenues": {"value": 13782000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -101324000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_average_shares": {"value": 110188000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_average_shares": {"value": 110188000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 114857000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -741000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -76899000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 37217000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -741000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 37217000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 114857000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -76899000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "balance_sheet": {"assets": {"value": 925275000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 322913000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 343334000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 581941000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "wages": {"value": 16830000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities_and_equity": {"value": 925275000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 748422000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 176853000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 63636000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 83127000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_payable": {"value": 13260000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": 748422000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 93726000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 20421000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}}}, {"start_date": "2025-04-01", "end_date": "2025-06-30", "filing_date": "2025-08-07", "acceptance_datetime": "2025-08-07T20:06:00Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-104987", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-104987/files/ntla-20250630_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -101255000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -101659000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -99622000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -32662000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 106910000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -99622000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 106910000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -32662000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": -39950000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": -39950000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "income_statement": {"other_operating_expenses": {"value": 27206000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss": {"value": -101255000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -0.98, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "diluted_average_shares": {"value": 103732000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -109996000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -101255000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -0.98, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -101255000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 14245000.0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -101255000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 124241000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": -101255000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "benefits_costs_expenses": {"value": 124241000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "basic_average_shares": {"value": 103732000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "research_and_development": {"value": 97035000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 124241000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}}, "balance_sheet": {"other_current_liabilities": {"value": 73292000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 95499000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 898894000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 715255000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 402949000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "wages": {"value": 12405000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity": {"value": 715255000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 495945000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 22806000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities": {"value": 183639000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_assets": {"value": 380143000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 898894000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 9802000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-08", "acceptance_datetime": "2025-05-08T20:05:38Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-066914", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-066914/files/ntla-20250331_htm.xml", "financials": {"balance_sheet": {"equity_attributable_to_parent": {"value": 779919000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "wages": {"value": 9845000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_liabilities": {"value": 112593000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 551392000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 986163000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 409648000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "fixed_assets": {"value": 25123000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": 779919000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 12364000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 986163000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 206244000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 434771000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 90384000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "income_statement": {"costs_and_expenses": {"value": 137434000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -114329000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 29007000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -114329000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -114329000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_average_shares": {"value": 103500000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "revenues": {"value": 16627000.0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 108427000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_average_shares": {"value": 103500000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 137434000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_earnings_per_share": {"value": -1.1, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_earnings_per_share": {"value": -1.1, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "benefits_costs_expenses": {"value": 130956000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss": {"value": -114329000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -120807000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -114329000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -114329000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -113877000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 94328000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 54602000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -148930000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 94328000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -148930000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 54602000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-07", "acceptance_datetime": "2024-11-07T21:05:30Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-123276", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-123276/files/ntla-20240930_htm.xml", "financials": {"income_statement": {"benefits_costs_expenses": {"value": 153881000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -144770000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -135712000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -135712000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": 101002000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_equity_method_investments": {"value": 0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "costs_and_expenses": {"value": 153881000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "diluted_average_shares": {"value": 101002000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -135712000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_earnings_per_share": {"value": -1.34, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "research_and_development": {"value": 123380000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 30501000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_earnings_per_share": {"value": -1.34, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_income_loss": {"value": -144770000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 9111000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -135712000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 153881000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "balance_sheet": {"current_liabilities": {"value": 105683000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 462449000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 1173351000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 433686000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 13145000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 105053000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 962615000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 962615000.0, "unit": "USD", "label": "Equity", "order": 1400}, "wages": {"value": 20551000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities": {"value": 210736000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 710902000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 1173351000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 28763000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 71987000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 82192000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -7709000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -10354000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -7709000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -84837000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -10354000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 82192000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -84837000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -131260000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -131260000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -131260000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-08", "acceptance_datetime": "2024-08-08T20:06:13Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-093907", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-093907/files/ntla-20240630_htm.xml", "financials": {"income_statement": {"revenues": {"value": 6957000.0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 31793000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_income_loss": {"value": -139043000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -146975000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 146000000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": 96975000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -146975000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 146000000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_equity_method_investments": {"value": 0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -1.52, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "research_and_development": {"value": 114207000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -146975000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_average_shares": {"value": 96975000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -146975000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -146975000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 146000000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "basic_earnings_per_share": {"value": -1.52, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -146975000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -147183000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": -41130000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -41130000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 41246000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -58186000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -24190000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -24190000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -58186000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 41246000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "balance_sheet": {"liabilities": {"value": 220474000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 757211000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 434325000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "wages": {"value": 14901000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities_and_equity": {"value": 1191536000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 971062000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 18816000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 30273000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 71373000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 404052000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 1191536000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 971062000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 105090000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-09", "acceptance_datetime": "2024-05-09T20:25:24Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-057046", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-057046/files/ntla-20240331_htm.xml", "financials": {"balance_sheet": {"liabilities_and_equity": {"value": 1259589000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 375546000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 884043000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 1259589000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 343471000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "wages": {"value": 10386000.0, "unit": "USD", "label": "Wages", "order": 730}, "fixed_assets": {"value": 32075000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 1036137000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 13689000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": 1036137000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_liabilities": {"value": 73837000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 223452000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 97912000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -107436000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -108257000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -107436000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -107436000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 28935000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -107436000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_earnings_per_share": {"value": -1.12, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -107436000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -114003000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 136371000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_average_shares": {"value": 95502000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_earnings_per_share": {"value": -1.12, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_equity_method_investments": {"value": 0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "research_and_development": {"value": 111847000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 31091000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_average_shares": {"value": 95502000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_expenses": {"value": 142938000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -107436000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 142938000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -120662000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 59992000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 59992000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -120662000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 5901000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -54769000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -54769000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 5901000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "financials": {"income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -132161000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -132161000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": 566000, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": -1917000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_equity_method_investments": {"value": -4728000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "research_and_development": {"value": 108981000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -132161000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -132161000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "other_operating_expenses": {"value": 28994000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_income_loss": {"value": -139892000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_before_equity_method_investments": {"value": -127433000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "operating_expenses": {"value": 137975000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "benefits_costs_expenses": {"value": 130244000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 137975000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "diluted_average_shares": {"value": 566000, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -1.46, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_earnings_per_share": {"value": -1.46, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -132161000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 1300977000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 1050169000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 32760000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 115208000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 1050169000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 269887000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 302647000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "wages": {"value": 26615000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities": {"value": 250808000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 1300977000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 998330000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 81141000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 7452000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 135600000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -93054000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 45939000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 106484000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 106484000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 45939000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 59369000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 59369000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -93054000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 1314000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -130847000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -130847000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-11-09", "acceptance_datetime": "2023-11-09T21:05:36Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-062011", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-062011/files/ntla-20230930_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": -121928000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -121928000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -121928000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"research_and_development": {"value": 113696000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 11992000.0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -122224000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -122224000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "costs_and_expenses": {"value": 143099000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_income_loss": {"value": -131107000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_equity_method_investments": {"value": -3857000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "basic_average_shares": {"value": 88645000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "other_operating_expenses": {"value": 29403000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_before_tax": {"value": -131107000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -122224000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_before_equity_method_investments": {"value": -127250000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "diluted_average_shares": {"value": 88645000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "benefits_costs_expenses": {"value": 143099000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_earnings_per_share": {"value": -1.38, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_earnings_per_share": {"value": -1.38, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_expenses": {"value": 143099000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -122224000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}}, "balance_sheet": {"liabilities_and_equity": {"value": 1243349000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 205935000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 1243349000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 349856000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 893493000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "wages": {"value": 21006000.0, "unit": "USD", "label": "Wages", "order": 730}, "noncurrent_liabilities": {"value": 113982000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 1037414000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_noncurrent_assets": {"value": 316056000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_liabilities": {"value": 67394000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": 1037414000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 3553000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 33800000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 91953000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 19102000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -101381000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -2779000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 79500000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -101381000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 79500000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 19102000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -2779000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-03", "acceptance_datetime": "2023-08-03T20:13:53Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-037996", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-037996/files/ntla-20230630_htm.xml", "financials": {"income_statement": {"basic_earnings_per_share": {"value": -1.4, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_average_shares": {"value": 88185000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -123681000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_equity_method_investments": {"value": -4000000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -123681000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -1.4, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "revenues": {"value": 13594000.0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 30652000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "research_and_development": {"value": 115276000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "benefits_costs_expenses": {"value": 145928000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_income_loss": {"value": -132334000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "costs_and_expenses": {"value": 145928000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss": {"value": -123681000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -123681000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -123681000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_average_shares": {"value": 88185000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_expenses": {"value": 145928000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_before_equity_method_investments": {"value": -128334000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 2516000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -34538000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -122345000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 2516000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -90323000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -34538000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -90323000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -122345000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -124871000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -123681000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"equity_attributable_to_parent": {"value": 1104888000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 33194000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 1323240000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 11634000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 72504000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "wages": {"value": 15713000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities": {"value": -1104888000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 1104888000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 1323240000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 383625000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 939615000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 350431000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 99851000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-04", "acceptance_datetime": "2023-05-04T20:12:48Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-017866", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-017866/files/ntla-20230331_htm.xml", "financials": {"income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -103126000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": 87772000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_earnings_per_share": {"value": -1.17, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_equity_method_investments": {"value": -3048000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "revenues": {"value": 12606000.0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 124564000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": -103126000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_before_equity_method_investments": {"value": -100078000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "benefits_costs_expenses": {"value": 115732000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "research_and_development": {"value": 97116000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "costs_and_expenses": {"value": 124564000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -103126000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_average_shares": {"value": 87772000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "other_operating_expenses": {"value": 27448000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -103126000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -1.17, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -111958000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -103126000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -98343000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -98343000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 4783000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 2221000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -122248000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 2221000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -229355000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -229355000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -122248000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -109328000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -109328000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "balance_sheet": {"liabilities_and_equity": {"value": 1417889000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 103383000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 1190843000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 227046000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 1417889000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 1190843000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 422612000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "fixed_assets": {"value": 31606000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_liabilities": {"value": 123663000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 454218000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 86432000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "wages": {"value": 10061000.0, "unit": "USD", "label": "Wages", "order": 730}, "accounts_payable": {"value": 6890000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 963671000.0, "unit": "USD", "label": "Current Assets", "order": 200}}}}, {"start_date": "2022-10-01", "end_date": "2022-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2022", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -111500000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -111500000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 1907000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": -113407000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -113407000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "costs_and_expenses": {"value": 123660000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "research_and_development": {"value": 100034000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -113407000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 23626000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "revenues": {"value": 13573000.0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_average_shares": {"value": 1429000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_average_shares": {"value": 1429000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": -113407000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 123660000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "benefits_costs_expenses": {"value": 126980000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_earnings_per_share": {"value": -1.38, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_before_equity_method_investments": {"value": -110159000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "income_loss_from_equity_method_investments": {"value": -3248000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "operating_income_loss": {"value": -110087000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_earnings_per_share": {"value": -1.38, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -113407000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "balance_sheet": {"noncurrent_liabilities": {"value": 157976000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 1216797000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 126554000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 1520114000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 275396000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 5154000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 303317000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 1235584000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 27921000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities": {"value": 284530000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "wages": {"value": 21778000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity": {"value": 1235584000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_liabilities": {"value": 99622000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 1520114000.0, "unit": "USD", "label": "Assets", "order": 100}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": 385742000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -89869000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -30152000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": 385742000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -89869000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -30152000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 505763000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 505763000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}}}, {"start_date": "2022-07-01", "end_date": "2022-09-30", "filing_date": "2022-11-03", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2022", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-021835", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-021835/files/ntla-20220930_htm.xml", "financials": {"income_statement": {"net_income_loss": {"value": -113229000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 118796000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": -105530000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 76047000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "basic_earnings_per_share": {"value": -1.49, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_before_equity_method_investments": {"value": -103696000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "net_income_loss_attributable_to_parent": {"value": -113229000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 22145000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -113229000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -113229000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 13266000.0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 96651000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_average_shares": {"value": 76047000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -105530000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_equity_method_investments": {"value": -1834000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "benefits_costs_expenses": {"value": 118796000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_earnings_per_share": {"value": -1.49, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "costs_and_expenses": {"value": 118796000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -113043000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -113043000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -113043000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"current_liabilities": {"value": 131132000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 108825000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 259507000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 128375000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "wages": {"value": 17923000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities_and_equity": {"value": 1084458000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 198914000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 225511000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 26597000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 858947000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 824951000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 824951000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 4384000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 1084458000.0, "unit": "USD", "label": "Assets", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 23977000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -78526000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -78526000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -6906000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -6906000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 23977000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 47643000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 47643000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}, {"start_date": "2022-04-01", "end_date": "2022-06-30", "filing_date": "2022-08-04", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2022", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-014731", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-014731/files/ntla-20220630_htm.xml", "financials": {"balance_sheet": {"wages": {"value": 12879000.0, "unit": "USD", "label": "Wages", "order": 730}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 103366000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 1110424000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": -880547000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 214991000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 25868000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_noncurrent_assets": {"value": 189123000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 1110424000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 880547000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 7515000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 895433000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 880547000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 123760000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "income_statement": {"income_loss_from_equity_method_investments": {"value": -3252000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "net_income_loss": {"value": -100678000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": -100678000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -98301000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_average_shares": {"value": 75823000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_parent": {"value": -100678000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_average_shares": {"value": 75823000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_earnings_per_share": {"value": -1.33, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_earnings_per_share": {"value": -1.33, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "costs_and_expenses": {"value": 112331000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "other_operating_expenses": {"value": 22132000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -100678000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 14030000.0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "benefits_costs_expenses": {"value": 112331000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 112331000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_before_equity_method_investments": {"value": -95049000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -100678000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "research_and_development": {"value": 90199000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 5895000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -85091000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 5895000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 95345000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -85091000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 16149000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 95345000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 16149000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -100678000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -102170000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2022-01-01", "end_date": "2022-03-31", "filing_date": "2022-05-05", "acceptance_datetime": "2022-05-05T20:06:30Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2022", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-007805", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-007805/files/ntla-20220331_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -152302000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -146872000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -5430000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}, "income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 133095000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -146872000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -146872000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_earnings_per_share": {"value": -1.96, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "revenues": {"value": 11252000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -146872000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_earnings_per_share": {"value": -1.96, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "diluted_average_shares": {"value": -541000, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "costs_and_expenses": {"value": 155498000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "other_operating_expenses": {"value": 22403000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "benefits_costs_expenses": {"value": 158124000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 155498000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": -541000, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_equity_method_investments": {"value": -2745000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "operating_income_loss": {"value": -144246000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -146872000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -146872000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_before_equity_method_investments": {"value": -144127000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}}, "balance_sheet": {"other_noncurrent_assets": {"value": 303724000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 10138000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 23697000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_assets": {"value": 327421000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 104823000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": 953754000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": -953754000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 126111000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "wages": {"value": 11150000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities_and_equity": {"value": 1202788000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 875367000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 1202788000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 953754000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -79801000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 47320000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -79801000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 47320000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 14992000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 47473000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 14992000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 47473000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}, {"start_date": "2021-10-01", "end_date": "2021-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2021", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "financials": {"income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "research_and_development": {"value": 71161000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -81237000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 93269000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "other_operating_expenses": {"value": 22108000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss": {"value": -81237000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 93269000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -81237000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -81237000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "benefits_costs_expenses": {"value": 94091000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -81237000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 12854000.0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -80415000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}, "balance_sheet": {"assets": {"value": 1294464000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 128387000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 769303000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 95821000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 125833000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 20968000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 9653000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 254220000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_assets": {"value": 504193000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": 1040244000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "wages": {"value": 20359000.0, "unit": "USD", "label": "Wages", "order": 730}, "liabilities_and_equity": {"value": 1294464000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 525161000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 1040244000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -83695000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -83695000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -2458000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -332000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -54651000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -159115000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -211486000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -211486000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -54651000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -159115000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 2280000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 2280000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}}}, {"start_date": "2021-07-01", "end_date": "2021-09-30", "filing_date": "2021-11-04", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2021", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-21-003088", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-21-003088/files/ntla-20210930_htm.xml", "financials": {"balance_sheet": {"noncurrent_liabilities": {"value": 130296000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 227863000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 520187000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 97567000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 1107098000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 19946000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 1334961000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 1107098000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 7470000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "wages": {"value": 11828000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_current_liabilities": {"value": 78269000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 814774000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_assets": {"value": 500241000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities_and_equity": {"value": 1334961000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -65022000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -65022000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 204277000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -399381000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 204277000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 668680000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -399381000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 668680000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "income_statement": {"other_operating_expenses": {"value": 18711000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -71644000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "benefits_costs_expenses": {"value": 79197000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_income_loss": {"value": -71993000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "costs_and_expenses": {"value": 79197000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_expenses": {"value": 79197000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -71644000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 60486000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -71644000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 7204000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -71993000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -71644000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -71805000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -71805000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -71805000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -161000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}}}, {"start_date": "2021-04-01", "end_date": "2021-06-30", "filing_date": "2021-08-05", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2021", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-21-041673", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-21-041673/files/ntla-10q_20210630_htm.xml", "financials": {"income_statement": {"operating_income_loss": {"value": -69017000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -68806000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -68806000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 75567000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss": {"value": -68806000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -68806000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 6550000.0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 75567000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "benefits_costs_expenses": {"value": 75567000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "research_and_development": {"value": 58884000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": -68806000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "other_operating_expenses": {"value": 16683000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "balance_sheet": {"accounts_payable": {"value": 6854000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "wages": {"value": 10039000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_assets": {"value": 549404000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 672243000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 494813000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 122839000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 18530000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_assets": {"value": 104309000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_liabilities": {"value": 57070000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": -494813000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 672243000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 494813000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 73963000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -68806000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -68807000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -1000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -52981000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -12588000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -12588000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 33260000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 7133000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -52981000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 33260000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 7133000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}}}, {"start_date": "2021-01-01", "end_date": "2021-03-31", "filing_date": "2021-05-06", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2021", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-21-024947", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-21-024947/files/ntla-10q_20210331_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -13000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -46205000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -46218000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -46205000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 13594000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -46205000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "benefits_costs_expenses": {"value": 52650000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_income_loss": {"value": -46425000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 52870000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss": {"value": -46205000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "costs_and_expenses": {"value": 52870000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -46205000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 6445000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -46205000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 39276000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}, "balance_sheet": {"liabilities": {"value": -545873000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "wages": {"value": 6244000.0, "unit": "USD", "label": "Wages", "order": 730}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 716891000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 99650000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": 545873000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 16157000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 45770000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 8688000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities_and_equity": {"value": 716891000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 601084000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 545873000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 60702000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 115807000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -25542000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 58595000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -52376000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -19323000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 58595000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -25542000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -19323000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -52376000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}}}, {"start_date": "2020-10-01", "end_date": "2020-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2020", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -30000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -42192000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -42192000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"operating_expenses": {"value": 48994000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "research_and_development": {"value": 38231000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "costs_and_expenses": {"value": 48994000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -42192000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -42399000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "benefits_costs_expenses": {"value": 48994000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss": {"value": -42192000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -42192000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -42192000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "other_operating_expenses": {"value": 10763000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -42399000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 6595000.0, "unit": "USD", "label": "Revenues", "order": 100}}, "balance_sheet": {"other_current_liabilities": {"value": 42874000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "wages": {"value": 10920000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity_attributable_to_parent": {"value": 527072000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 149250000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 84996000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 676322000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 59805000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_noncurrent_assets": {"value": 43862000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": 527072000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 676322000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 64254000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 15943000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 10460000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 616517000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -210918000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -40226000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -210918000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -40226000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 234093000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 234093000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -17051000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -17051000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}}}, {"start_date": "2020-07-01", "end_date": "2020-09-30", "filing_date": "2020-11-05", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2020", "cik": "0001652130", "sic": "2835", "tickers": ["NTLA"], "company_name": "Intellia Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-20-050915", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-20-050915/files/ntla-10q_20200930_htm.xml", "financials": {"income_statement": {"net_income_loss": {"value": -27840000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -27840000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -28102000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -27840000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "benefits_costs_expenses": {"value": 50322000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 50322000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "revenues": {"value": 22220000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -28102000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 10566000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_expenses": {"value": 50322000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 39756000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_available_to_common_stockholders_basic": {"value": -27840000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "cash_flow_statement": {"net_cash_flow": {"value": -181941000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -181941000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -153980000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -28558000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -153980000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 597000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -28558000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 597000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "balance_sheet": {"accounts_payable": {"value": 7775000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "assets": {"value": 458555000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 55865000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "wages": {"value": 8642000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_current_liabilities": {"value": 39448000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 416250000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 73070000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 15612000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities": {"value": 128935000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 42305000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_noncurrent_assets": {"value": 26693000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": 329620000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 329620000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 458555000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "comprehensive_income": {"other_comprehensive_income_loss_attributable_to_parent": {"value": -124000, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss": {"value": -27840000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -27964000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}]